Stock Analiz

Akanda Corp. AKAN

Medicinal Chemicals and Botanical Products · IPO 2022 · data as of November 13, 2026

$1.36Market cap $3M
Open the interactive analysis →

Akanda Corp. (AKAN) is a healthcare company listed in the US with a market value of about $3M. In fiscal year 2024 it had revenue of $836664 and net income of -$4M, a net margin of -489.6%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -2134%.

About Akanda

Akanda is listed in the US and classified in medicinal chemicals and botanical products, IPO year 2022. Revenue went from $2062 in 2020 to $836664 in 2024, growth of about 348.8% a year. It was profitable in 0 of the last 6 years in our data.

Score: 1.2 / 5

Value0/5
Future growth4/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S3.9
P/B0.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-187.2%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)97.5%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-27955.6%
ROIC (5-yr avg.)-2133.8%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 6 years

Fiscal year202420232022202120202019
Revenue$836664$423683$3M$41431$2062—
Net income-$4M-$32M-$12M-$8M-$2M-$1M
Free cash flow-$6M-$2M-$12M-$7M——
EPS (diluted)$-1.72$-13.51$-4.88$-3.40$-0.96$-0.58
Net margin-489.6%-7617.7%-445.0%-19625.9%-111600.0%—
ROIC-74.8%-8363.1%-52.3%-45.0%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Akanda pay a dividend?

Not currently.

Is Akanda a good stock to buy?

We do not give buy or sell advice. Akanda scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.